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Throughout development, canonical Wnt signaling contributes to the formation 
and maintenance of a wide array of cells, tissues, and organs.  Dys-regulated Wnt 
signaling during embryonic development is implicated in developmental defects known 
as neurochristopathies, including craniofacial and heart defects, as well as defects in 
neural development.  Due to its roles in stem cell maintenance and self-renewal, tissue 
homeostasis, and regeneration, aberrant Wnt signaling in adult tissues can result in 
various forms of cancer, including colorectal cancer, breast cancer, lung cancer, and 
gastro-intestinal cancer, among others.  Dys-regulated Wnt signaling is also implicated 
in other pathologies including bone disease, and metabolic diseases, such as Type II 
diabetes.  Our lab has previously identified a novel crosstalk between canonical Wnt 
signaling and ephrin signaling.  Ephrin signaling occurs through the interaction of ephrin 
ligands and Eph receptor tyrosine kinases, and is bidirectional.  Due to the roles of 
ephrin signaling in tissue development and maintenance, aberrant ephrin signaling is 
implicated in many diseases including bone remodeling diseases, diabetes, and cancer.  
The molecular mechanism of the crosstalk between canonical Wnt signaling and ephrin-
B signaling remains unknown.  β-catenin is a key intracellular effector of canonical Wnt 
signaling that transduces the signal to the nucleus, where β-catenin interacts with the 
TCF/LEF transcription factors and activates transcription of target genes.  Due to its 
central role in transducing the canonical Wnt signal to the nucleus, we predict that 
ephrin-B signaling antagonizes canonical Wnt signaling by affecting the stability and/or 
sub-cellular localization of β-catenin, or the interaction between β-catenin and TCF/LEF 
transcription factors.  By employing mouse ephrin-B constructs in human cell lines, we 
show that the canonical Wnt - ephrin-B crosstalk is conserved between frogs and 
mammals.  We also found that ephrin-B antagonism of canonical Wnt signaling is likely 
independent of ubiquitin proteasome system (UPS)-mediated degradation of β-catenin. 
Furthermore, confocal immunofluorescence microscopy revealed that overexpression of 
ephrin-B in HEK293T cells treated with lithium chloride (LiCl) seems to promote 
membrane localization of β-catenin, particularly at the apical Z sections.  These results 
suggests that re-localization of β-catenin to the cell membrane may contribute to the 









We stare straight into nothing 
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Chapter 1: Introduction 
1.1: Canonical Wnt Signaling 
1.1.1: Canonical Wnt Signaling 
There are 19 identified mammalian Wnt homologs, which include 22 cysteine 
residues whose spacing and arrangement is highly conserved, a signal sequence for 
secretion, and potential glycosylation sites (Kikuchi, 2011; Mikels, 2006).  Wnt ligands do not 
function as a classical morphogen by establishing a chemical gradient, but instead 
mediate close range signaling between cells that are close to one another (Clevers, 2012).  
Wnt ligands are palmitoylated in the endoplasmic reticulum (ER) by the Porcupine 
(Porc) enzyme, and are glycosylated to ensure proper secretion (Takada, 2006; Lorenowicz, 2009; 
Port, 2010; Herr, 2012; Clevers, 2012).  Palmitoylated Wnt ligands are transported to the Golgi 
network where they bind to the Evi/Wntless multi-pass transmembrane protein (Takada, 
2006; Lorenowicz, 2009; Port, 2010; Herr, 2012; Clevers, 2012).  The Wnt/Evi/Wntless complexes are 
secreted from the Golgi network in endosomal vesicles, which transport Wnt ligands to 
the plasma membrane to be secreted from the cell (Takada, 2006; Lorenowicz, 2009; Port, 2010; Herr, 
2012; Clevers, 2012).  Wnt ligands were first found to bind the cysteine rich domain (CRD) of 
Frizzled (Fz), a 7-transmembrane protein of the GPCR family (Bhanot, 1996).  The 
palmitoleic acid group extends from the “thumb” region of the Wnt ligand into the 
cysteine rich domain (CRD) of Fz, reinforcing the Wnt-Fz interaction (Takada, 2006; Lorenowicz, 
2009; Port, 2010; Herr, 2012; Clevers, 2012).  A single Wnt can bind multiple Fz receptors and a single 
Fz receptor can also bind multiple Wnt ligands (Bhanot, 1996).  Upon binding of Wnt ligand, 
Fz forms receptor complexes with co-receptors, including low-density lipoprotein 
receptor-related proteins 5/6 (LRP5/6), receptor Tyr kinase-like orphan receptors 1/2 
(Ror1/2), and protein Tyr kinase 7 (PTK7) (Li, 2005; Grumolato, 2010; Peradziryi, 2012).   
Wnt ligands also bind various agonists, such as the R-spondin family and Norrin, 
and antagonists, such as Cerberus, Dickopf-related protein 1 (DKK1), secreted Frizzled-
related protein (SFRP), Wnt inhibitory factor (WIF), Sclerostin (and its homologue 
Wise), which regulate Wnt signaling by affecting the assembly of ligand – receptor 
complexes and/or the recruitment of co-receptors, or by affecting receptor endocytosis 
2 
 
(Cruciat, 2012; Niehrs, 2012).  Furthermore, Wnt ligands have since been found to also bind 
alternate receptors independently of Fz through their interaction with a CRD and/or a 
Wnt inhibitory factor (WIF) domain (Mikels, 2006).  In this manner, Wnt ligands were found to 
bind the CRDs of Ror and the muscle skeletal receptor Tyr kinase (MUSK), as well as 
the WIF domain of the cell surface atypical receptor tyrosine kinase, receptor Tyr 
kinase (Ryk).  These receptors may function as alternate receptors and/or Fz co-
receptors (Mikels, 2006).  Specific combinations of Wnt ligands, receptors, co-receptors, and 
cellular context induce various downstream signaling events which induce different 
cellular responses.  Depending on the induced downstream signaling events and the 
cellular responses elicited, Wnt signaling is defined as either canonical or non-
canonical.  Generally speaking, canonical Wnt signaling involves binding of Wnt ligands 
to Fz/LRP5/6, resulting in the stabilization and nuclear localization of the intracellular 
effector, β-catenin, which in turn binds to T-cell/lymphoid enhancer factor (TCF/LEF) 
transcription factors and activates transcription of canonical Wnt target genes.  Non-
canonical Wnt signaling, however, involves Wnt5a, Wnt11, or other Wnt ligands binding 
to alternate Wnt receptors, such as Ryk, Ror, and MUSK, or to Fz, which recruits 
alternate co-receptors, ultimately resulting in activation of distinct downstream 
intracellular signaling events which may not involve stabilization and nuclear localization 
of β-catenin. Accordingly, canonical Wnt signaling is commonly referred to as β-catenin 
dependent Wnt signaling, while non-canonical Wnt signaling is commonly referred to as 
β-catenin independent Wnt signaling.  Canonical Wnt signaling will be our focus 
heretofore. 
Canonical Wnt signaling is activated during embryonic development, as well as in 
proliferating, migrating, and differentiating cells in adult tissues (Teo, 2010; Schambony, 2013; 
Aman, 2008).  Canonical Wnt signaling plays key roles in embryonic development, 
contributing to processes of axis patterning, cell fate specification, cell polarity, cell 
proliferation, and cell migration (Peterson, 2009; Hikasa, 2013; Clevers, 2006a; van Amerongen, 2009).  
Canonical Wnt is involved in gastrulation and body axis formation, including 
specification of anteroposterior and dorsoventral axes (van Amerongen, 2009; Hikasa, 2013; Peterson, 
2009).  Canonical Wnt signaling induces mesoderm and endoderm during embryonic 
development, and contributes to hematopoiesis (Clevers, 2006a).  At later stages, canonical 
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Wnt signaling also contributes to the formation and maintenance of cartilage and bone, 
heart, muscle, neurons of the peripheral and central nervous systems, skin, blood cells, 
and other tissues (Regard, 2012; Baron, 2013; Buikema, 2014; von Maltzahn, 2012; Patthey, 2008; Salinas, 2012; Lim, 
2013; Lento, 2013).  One example of the function of canonical Wnt signaling in development is 
its involvement in the induction of neural crest cells, which migrate throughout the 
embryo and differentiate, contributing to multiple tissues and organs including the 
peripheral nervous system, the heart, and craniofacial bone and cartilage (Elkouby, 2010; Wu, 
2005; Le Douarin,1999).  Dys-regulated Wnt signaling affects neural crest cell development, 
and is implicated in developmental defects known as neurochristopathies, including 
craniofacial and heart defects, as well as defects in neural development (Etchevers, 2006; 
Alexander, 2014; Veerle, 2008; Patthey, 2008).  
Canonical Wnt signaling is also involved in stem cell maintenance and self-
renewal, tissue homeostasis, regeneration, and regulates insulin sensitivity in cells 
(Clevers, 2014; Clevers, 2012; Palsgaard, 2012; Abiola, 2009).   Aberrant Wnt signaling can result in various 
forms of cancer, including colorectal cancer, gastrointestinal cancer, breast cancer, lung 
cancer, glioblastoma, leukemia, melanoma, among others (Clevers, 2012; Giles, 2003; Morin, 1997; 
Logan, 2004; Reya, 2005; Bienz, 2000; de Lau, 2007; Schepers, 2012; Howe, 2004; Nguyen, 2009; Rheinbay, 2013; Damsky, 
2011).  Aberrant Wnt signaling contributes to oncogenesis by promoting tumor cell 
proliferation and metastasis (Polakis, 2012; Clevers, 2012; Reya, 2005; Nguyen, 2009).  Canonical Wnt 
mutations that result in these cancers include mutations to β-catenin, mutations to APC 
and other components of the β-catenin destruction complex, overexpression of Wnt 
ligands, loss of inhibitors, and decreased activity of other signaling pathways that 
regulate canonical Wnt signaling (Morin, 1997; Polakis, 2012; Clevers, 2012; Reya, 2005; Logan, 2004).  In 
addition to developmental defects and its roles in carcinogenesis, dys-regulated Wnt 
signaling is implicated in other pathologies including bone disease, and metabolic 
diseases, such as Type II diabetes (Baron, 2013; Herr, 2012; Clevers, 2012). 
1.1.2: Dual Roles of β-catenin: β-catenin Structure and Function  
β-catenin is a key intracellular effector of canonical Wnt signaling that transduces 
the signal to the nucleus, where β-catenin interacts with the TCF/LEF transcription 
factors and activates transcription of Wnt/β-catenin target genes (Cadigan, 2012).  However, 
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non-canonical Wnt signaling, as mentioned earlier, is independent of β-catenin (van 
Amerongen, 2012).  In addition to its role in signaling, β-catenin plays a critical role in 
stabilizing cell-cell adherens junctions by interacting with classical cadherins such as E-
cadherin, a transmembrane protein, and linking it to cytoskeletal structures (Conacci-Sorrell, 
2003).  The recruitment and retention of β-catenin at adherens junctions through its 
binding to the cytoplasmic tail of E-cadherin result in a pool of intracellular, membrane-
bound β-catenin in the cell.  Along with the negative regulatory activity of the β-catenin 
destruction complex, a micro-environment that is restrictive of canonical Wnt signaling 
emerges in cells participating in many cell-cell interactions and free of Wnt ligand 
stimulation (i.e. cells that form tissues in vivo, and dense culture conditions in vitro). 
This phenomenon results in a decrease in nuclear β-catenin levels and Wnt signaling 
activation (Conacci-Sorrell, 2003). Due to this phenomenon, dense cell cultures have lower 
nuclear β-catenin and Wnt signaling activation than sparse cell cultures (Conacci-Sorrell, 2003).  
The ability of β-catenin to participate in these diverse activities within the cell is 
elucidated by its structure.   
β-catenin, a member of armadillo multigene family, is a 90 kDa protein, and is 
781 amino acids long (in humans), consisting of flexible N-terminal and C-terminal 
domains (NTD, CTD) flanking a rigid central region made up of 12 Armadillo repeats 
(Valenta, 2012).  The CTD is linked to the central region by a conserved helix, Helix-C (Xing, 
2008).  The various interaction partners of β-catenin bind to the long, positively charged 
groove of the Armadillo repeats by forming salt bridges with Lys312 and Lys435 (Valenta, 
2012).  Only one of these interaction partners, including E-cadherin, adenoma polyposis 
coli (APC), and TCF/LEF, can bind to β-catenin at a time, creating competition for β-
catenin and regulating the function of β-catenin based on its availability and subcellular 
localization (Figure 1) (Krieghoff, 2006; Valenta, 2012; Morgan, 2014).  Accordingly, maintenance of 
different pools of β-catenin within the cell and post-translational modifications control the 
spatial separation, retention, and stability of β-catenin, contributing to its dual role as a 




Figure 1: β-catenin ARM Domain Interactors.  E-cadherin, Axin, APC, and the 
TCF/LEF transcription factors are known to interact with the ARM domain of β-catenin.  
Only one of these interaction partners, including E-cadherin, adenoma polyposis coli 
(APC), and TCF/LEF, can bind to β-catenin at a time, creating competition for β-catenin 
and regulating the function of β-catenin based on its availability and subcellular 
localization (Image reprinted with permission from Creative Commons: Image by 




1.1.3: Regulation of β-catenin Stability  
The balance between sequestration of β-catenin by cadherins at adherens 
junctions and canonical Wnt signaling activity affects the levels of cytoplasmic β-catenin 
(Conacci-Sorrell, 2003; Valenta, 2012).  In the absence of Wnt signaling, cytoplasmic β-catenin is 
phosphorylated and ubiquitinated, marking it for degradation via the 26S proteasome by 
a multi-protein destruction complex that resides in the cytoplasm known as the β-
catenin destruction complex.  The β-catenin destruction complex, hereafter referred to 
solely as the destruction complex, consists of Dishevlled (Dvl), the scaffold proteins 
Axin and APC, the kinases glycogen synthase kinase 3 β (GSK3β) and casein kinase 1 
α (CK1α), the phosphatase protein phosphatase 2A (PP2A), and the E3 ubiquitin ligase 
F-box protein β-transducin repeat containing protein (β-TrCP) (Li, 2012b; Stamos, 2013; Valenta, 
2012; Clevers, 2012).  Cytoplasmic β-catenin binds to APC and Axin, which recruit β-catenin to 
the destruction complex (Li 2012; Clevers, 2012; Stamos 2013).  These interactions bring β-catenin 
in close proximity of CK1α and GSK3β, allowing their sequential phosphorylation of β-
catenin (Liu 2002; Zeng, 2005; Verheyen, 2010).  CK1α phosphorylates β-catenin at Ser45, which 
primes β-catenin for the subsequent sequential phosphorylation of Thr41, Ser37, and 
Ser33 by GSK3β (Liu 2002; Zeng, 2005; Verheyen, 2010).  Phosphorylation of β-catenin by GSK3β 
is dependent upon interaction of GSK3β with Axin and APC (Valenta, 2012).  These 
phosphorylation events result in the formation of the DSGXXS degron motif at the N-
terminal domain of β-catenin, which is recognized by the F-box protein β-transducin 
repeat containing protein (β-TrCP) (Lau, 2012; Clevers, 2012; Valenta, 2012).  APC protects the 
phosphorylated DSGXXS degron from dephosphorylation by PP2A (Su, 2008).  Binding of 
β-TrCP associates β-catenin with the E3 ubiquitin ligase complex, Skp1/Cul1/F-box/ β-
TrCP (SCF β-TrCP), resulting in the ubiquitination of β-catenin and its subsequent 
degradation by the 26S proteasome (Hart, 1999; Latres,1999; Li 2012; Stamos 2013; Valenta, 2012).  The 
degradation of cytoplasmic β-catenin by the destruction complex prevents cytoplasmic 
accumulation of β-catenin, thereby preventing the translocation of β-catenin to the 
nucleus and the initiation of transcription of Wnt target genes (Li, 2012b; Clevers, 2012; Stamos, 
2013; Valenta, 2012).  In addition to degradation of cytoplasmic β-catenin, transcription of 
Wnt/β-catenin target genes are further repressed by epigenetic events in the absence of 
Wnt signaling.  The co-repressor Groucho binds to TCF/LEF transcription factors in the 
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absence of Wnt signaling, and along with other epigenetic factors, inhibits the 
transcription of Wnt target genes (Roose, 1998; Daniels, 2005; Clevers, 2012; Valenta, 2012). 
Binding of Wnt ligands to Fz and LRP5/6 results in inhibition of the β-catenin 
destruction complex (Valenta, 2012).  In the presence of canonical Wnt ligand, Fz and 
LRP5/6 form a heterodimeric receptor complex (Valenta, 2012; Clevers, 2012).  The cytoplasmic 
tail of Fz interacts with Dvl, and the DIX domain of the associated Dvl is exposed upon 
binding of Wnt to Fz (Chen, 2003; Valenta, 2012).  Axin binds to the exposed DIX domain, 
recruiting the associated destruction complex components to the receptor complex 
(Schwarz-Romond, 2007; Fiedler, 2011; Clevers, 2012; Valenta, 2012).  This brings CK1γ/ε of the destruction 
complex into proximity of LRP5/6, allowing CK1γ/ε to phosphorylate LRP5/6, which 
blocks GSK3β activity (Liu, 2002; Zeng, 2005; Valenta, 2012).  This Wnt – induced inhibition of the β-
catenin destruction complex results in the stabilization of β-catenin in the cytoplasm, 
allowing β-catenin to translocate to the nucleus and initiate transcription of Wnt target 
genes by displacing the co-repressor Groucho and binding to TCF/LEF transcription 
factors, and recruiting other transcriptional co-activators and histone modifiers including 
Brg1, CBP/p300, Cdc47, Bcl9, and Pygopus (Li, 2012a; Clevers, 2012; Roose, 1998; Daniels, 2005; 
Mosimann, 2009; Hecht, 2000; Takemaru, 2000; Li, 2007; Brack, 2009; Schwab, 2007). The mechanisms by which 
β-catenin is transported into and out of the nucleus are not completely clear (Krieghoff, 2006; 





Figure 2: Canonical Wnt Signaling.  (Left) In the absence of Wnt ligand, LRP5/6 is 
not phosphorylated, and the destruction complex, consisting of Dvl, Axin, GSK3-β, APC, 
and β-TrCP, resides in the cytoplasm where it binds, phosphorylates, and ubiquitinates 
β-catenin, marking β-catenin for degradation by the proteasome.  (Right) Wnt ligands 
secreted from nearby cells bind to the Fz receptor, inducing the recruitment of the co-
receptors LRP5/6.  The assembly of this receptor complex triggers the association of 
the destruction complex with phosphorylated LRP.  The association of the destruction 
complex with the Wnt/Fz/Lrp5/6 receptor complex blocks the phosphorylation of β-
catenin by GSK3β, thus preventing recognition of β-catenin by β-TrCP and the 
subsequent degradation of β-catenin by the proteasome.  The net effect of these 
interactions is the stabilization of β-catenin in the cytoplasm, which allows β-catenin to 
enter the nucleus where it binds TCF/LEF transcription factors and regulates the 
transcription of canonical Wnt target genes (Image reprinted with permission from 
InTechOpen: Image Copyright © 2013 Inestrosa, N.C., Varela-Nallar, L. Published in 




Figure 3: Wnt Signaling in the Nucleus.  In the absence of Wnt signals, the co-
repressor Groucho binds to TCF and represses its target genes.  Following the 
activation of Wnt signaling and the subsequent stabilization of β-catenin in the 
cytoplasm, β-catenin migrates into the nucleus where it replaces Groucho from 
TCF/LEF and recruits transcriptional coactivators and histone modifiers such as Brg1, 
CBP, Cdc47, Bcl9, and Pygopus to drive the expression of canonical Wnt target genes 
(Image reprinted with permission from Elsevier Inc: Cell [Clevers, 2012] Copyright © 
2012 Elsevier Inc). 
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1.1.4: β-catenin Subcellular Localization 
Although it is widely accepted that cytoplasmic accumulation of β-catenin 
precludes nuclear translocation of β-catenin, the mechanism by which β-catenin is 
transported into and out of the nucleus is unclear (Valenta, 2012).  While proteins less than 
30 kDA are readily diffusible through the nuclear pores, proteins larger than 50 kDA, like 
β-catenin (90 kDA), require active transport via the nuclear receptor dependent 
(importin/exportin) pathways through the nuclear pore complex (NPC) (Morgan, 2014).  
Interestingly, β-catenin does not have a recognizable nuclear localization signal (NLS) 
or nuclear export signal (NES) necessary for transport through nuclear receptor 
dependent pathways, and does not require Ran-GTPase for transport (Eleftheriou, 2001; 
Fagotto, 1998; Wiechens, 2001; Yokoya, 1999).  Several proteins have been implicated in mediating 
nuclear import of β-catenin through the nuclear receptor dependent import pathway 
(importin α:β) by acting as chaperones, including adenomatous polyposis coli (APC), 
Ras-related C3 botulinum toxin substrate 1 (Rac1), Smad3/4, forkhead box M1 
(FoxM1), insulin receptor substrate 1 (IRS1), cell surface associated mucin 1 (MUC1), 
B-cell CLL/lymphoma 9 (BCL-9), and the androgen receptor (Henderson, 2000; Wang, 2014; Wu, 
2008; Jian, 2006; Li, 2006; Zhang, 2010; Zhang, 2011; Chen, 2005; Li, 2011; Wen, 2003; Brembeck, 2004; Krieghoff, 2006; 
Mulholland, 2002; Pawlowsk, 2002). 
In addition, the TCF/LEF transcription factors that are activated by β-catenin in 
the nucleus have also been proposed to chaperone β-catenin into the nucleus through a 
nuclear receptor-dependent pathway (Krieghoff, 2006; Molenaar, 1996; Behrens, 1996; Huber, 1996; Simcha, 
1998).  Similarly, several proteins have been implicated in mediating nuclear export of β-
catenin through the nuclear receptor dependent export pathway by binding 
chromosome maintenance region 1 (CRM1) and acting as chaperones, including APC, 
Axin, Chibby, menin, leucine zipper tumor suppressor 2 (LZTS2), p21-activated kinase 
4 (PAK4), and Kank (Henderson, 2000; Krieghoff, 2006; Neufeld, 2000a; Neufeld, 2000b; Rosin-Arbesfeld, 2003; Wang, 
2014; Cong, 2004; Wiechens, 2004; Li, 2008; Li, 2010; Cao, 2009; Thyssen, 2006; Li, 2012a; Wang, 2006). 
In contrast to chaperone-mediated transport of β-catenin through nuclear 
receptor dependent pathways, it has been demonstrated that β-catenin can be 
transported into and out of the nucleus through chaperone- and nuclear receptor-
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independent pathways (Eleftheriou, 2001; Fagotto, 1998; Wiechens, 2001; Yokoya, 1999).  The armadillo 
repeat sequences 10-12 (R10-12) of β-catenin directly bind phenylalanine-glycine FxFG 
or GLFFG repeats (FG repeats) of nucleoporins Nup62, Nup98, Nup153, and 
RanBP2/Nup358, facilitating transport of β-catenin through the NPC (Sharma, 2012).   Since 
the interaction partners of β-catenin generally bind armadillo repeat sequences 3-8 (R3-
8), R10-12 remain accessible, raising the possibility that β-catenin may shuttle its 
interaction partners into and out of the nucleus through these nuclear receptor and Ran-
GTPase independent mechanisms (Sharma, 2012).  Consistent with these mechanisms of β-
catenin transport, the subcellular localization of β-catenin may be controlled by retention 
through the relative abundance of β-catenin binding partners in the nucleus, cytoplasm, 




1.2: Ephrin Signaling 
1.2.1: Ephrin Signaling 
Wei et al. have previously identified a novel crosstalk between canonical Wnt 
signaling and ephrin signaling, which likely involves alteration of the stability of β-
catenin, and/or the sub-cellular localization of β-catenin (Wei, 2010).  Ephrin signaling 
occurs through the interaction of ephrin ligands and Eph receptor tyrosine kinases, and 
can be unidirectional (forward or reverse) or bidirectional (forward and reverse 
simultaneously), depending on the directions of signal flow (Pasquale, 2010).  Forward 
signaling occurs when the signal is transduced from the ephrin ligand-expressing cell 
into the Eph receptor-expressing cell, while reverse signaling occurs in the opposite 
direction, simultaneously activating molecular pathways downstream of ephrins and 
Ephs (Pasquale, 2010).  Bidirectional signaling occurs when both forward and reverse 
signaling occur simultaneously via the same Eph/ephrin interaction (Pasquale, 2010).  
Transmembrane Eph receptors exclusively bind membrane-tethered ephrin ligands, and 
therefore, ephrin signaling requires cell-cell contact (Klein, 2012).  There are two sub-
classes of Eph receptors, including EphA and EphB (Klein, 2012).  In general, EphA 
receptors bind glycosylphosphotidylinositol (GPI)-linked ephrin-A ligands, while EphB 
receptors bind transmembrane ephrin-B ligands, however, there are some Eph 
receptors that can bind both ligand subclasses (Pasquale, 2008; Klein, 2012).   
Ephrin ligands and Eph receptors interact in trans, inducing the formation of 
Eph/ephrin heterodimers (Klein, 2012).  These heterodimers bind to other Eph/ephrin 
heterodimers, forming heterotetramers, which assemble into higher-order clusters through the 
recruitment of other ligand-bound Eph receptors (Klein, 2012).  These higher-order clusters are 
required for forward and reverse ephrin signaling, and the strength of the forward and reverse 
signals increases with the recruitment of additional ligand-bound receptors (Klein, 2012; Kania, 2016).  
Interestingly, Eph receptor clusters can laterally recruit additional Eph receptors independent of 
ephrins (Klein, 2012).  Within the clusters of Eph/ephrins, different sets of the Eph/ephrins 
may participate in forward and/or reverse signaling simultaneously, resulting in the 
phenomena of parallel and anti-parallel signaling (Kania, 2016).  Parallel signaling occurs 
when two or more adjacent Eph/ephrins signal simultaneously in the same direction 
(forward or reverse) (Kania, 2016).  Anti-parallel signaling occurs when two or more adjacent 
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Eph/ephrins signal simultaneously in opposite directions (Kania, 2016).  In addition, ephrin-A 
ligands can interact in cis with co-receptors (Klein, 2012).  Eph/ephrins can interact with 
other ligand/receptor systems, integrating environmental signals and disparate signaling 
events, producing diverse outcomes in terms of development and tissue homeostasis, 
maintenance, and function. 
Eph receptors have a highly conserved domain organization, consisting of a 
globular ligand binding domain (LBD), a cysteine rich region that includes a Sushi and 
an epidermal growth factor (EGF)-like domain, two fibronectin type III domains (FN1 
and FN2), a transmembrane (TM) helix, an intracellular juxtamembrane (JM) region that 
features several conserved tyrosine (Y) residues, a tyrosine kinase domain (TK), a 
sterile-α motif (SAM) protein-protein interaction domain, and a C-terminal Psd-95, Dlg, 
and Z01 domain (PDZ)-binding motif (Pasquale, 2008; Klein, 2012).  Ephrin-A and ephrin-B 
ligands possess an extracellular receptor-binding domain (RBD) (Klein, 2012).  Ephrin-A 
ligands are GPI-anchored, while ephrin-B ligands have a TM helix, an intracellular 
region with several conserved tyrosine residues and a C-terminal PDZ-binding motif 
(Klein, 2012). 
The JM region of Eph receptors suppresses the intrinsic Eph kinase activity 
through auto-inhibition due to its inactive conformation (Wybenga-Groot, 2001).  Activation of 
Eph receptors results in phosphorylation of tyrosine residues (P) of the JM domain, 
which relieves the auto-inhibition (Klein, 2012).  The kinase domain adopts an active 
conformation, resulting in phosphorylation of the TK and SAM domains and initiation of 
downstream signaling events through phosphorylation of intracellular effectors (Klein, 2012).  
In addition, the tyrosine residues of the intracellular region of ephrin-Bs are 
phosphorylated in response to binding with Eph receptors (Kullander, 2002). 
Forward ephrin signaling activates intrinsic tyrosine kinase activity of the Eph 
receptors, regulating the recruitment and activity of intracellular effector proteins such 
as non-catalytic region of tyrosine kinase adaptor protein 1 (Nck1) and Nck2 (also 
known as Grb4), phosphoinositide 3-kinase (PI3K), Vav2 and Vav3, Src, α2-chimerin, 
and ephexins (Klein, 2012; Kania, 2016).  These effectors are coupled to Ras homology (Rho) 
subfamily of Ras-like small GTP-ases, including Ras-related C3 botulinum toxin 
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substrate 1 (Rac1), cell division control protein 42 homolog (Cdc42), and RhoA (Klein, 2012; 
Kania, 2016).  By regulating the activity of Src family kinases and Ras/Rho family GTP-ases, 
ephrin signaling affects cytoskeletal dynamics (Klein, 2012; Kania, 2016). 
These events lead to the recruitment of PDZ domain-containing proteins, and 
possibly other effectors, such as the SH2/SH3 adaptor Grb4, p21 protein (Cdc42/Rac)-
activated kinase 1 (Pak1), and dedicator of cytokinesis 1 (Dock180), which then elicit 
cellular responses.  Reelin can also bind to ephrin-B1 and ephrin-B3, leading to the 
activation of disabled 1 (Dab1), which elicits cellular responses.   
The mechanism of reverse ephrin-B signaling is not well understood, but one 
mechanism involves recruitment of Src family kinases and tyrosine phosphorylation of 
its intracellular domain (Xu, 2002; Klein, 2012; Kania, 2016).  These events lead to the recruitment 
of PDZ domain-containing proteins, and possibly other effectors, such as the SH2/SH3 
adaptor Grb4, p21 protein (Cdc42/Rac)-activated kinase 1 (Pak1), and dedicator of 
cytokinesis 1 (Dock180), which then elicit cellular responses (Xu, 2002; Klein, 2012; Kania, 2016).  
Reelin can also bind to ephrin-B1 and ephrin-B3, leading to the activation of disabled 1 
(Dab1), which elicits cellular responses (Kania, 2016).  Although ephrin-A ligands lack an 
intracellular region, and therefore are not phosphorylated intracellularly, they also 
participate in reverse signaling by coupling to co-receptors, such as the Src family 
tyrosine kinase, Fyn, and the receptor tyrosine kinase, Ret, which elicit cellular 
responses (Klein, 2012; Kania, 2016). 
Termination of Eph/ephrin signaling is achieved by ectodomain cleavage or 
endocytosis.  When co-expressed in the same cell, A distintegrin and metalloprotease 
domain (ADAM)-type proteases cleave ephrin-A and ephrin-B proteins in cis (Hattori, 2000).  
When expressed in an adjacent, opposing cell, ADAM-type proteases cleave ephrin-A 
and ephrin-B proteins in trans (Janes, 2005).  In addition, Eph receptors are cleaved by 
metalloproteases and γ-secretase (Bai, 2011).  Endocytosis of complete Eph/ephrin 
complexes from the cell membrane can also achieve termination of Eph/ephrin signaling 
(Klein, 2012).  Ephrin-B can be trans-endocytosed into the EphB-expressing cell and EphB 
can be trans-endocytosed into the ephrin-B-expressing cell (Klein, 2012).  The balance 
between uni- and bi-directional endocytosis may depend on cellular context, may result 
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in unique downstream signaling events, and contributes to the various functions of 
Eph/ephrins (Marston, 2003; Zimmer, 2003; Pitulescu, 2010; Klein, 2012). 
Ephrin signaling affects cytoskeletal dynamics, driving changes in cell shape and 
cell-cell contacts (Klein, 2012; Kania, 2016).  Through these mechanisms, ephrin signaling 
contributes to cell-cell repulsion/adhesion, segregation, positioning, migration, 
proliferation, and axon guidance (Klein, 2012; Kania, 2016).  These cellular responses underlie 
the roles of ephrin signaling in development, such as patterning, morphogenesis, and 
tissue boundary formation.  These cellular responses also underlie the roles of ephrin 
signaling in tissue homeostasis, maintenance, and function in adult tissues (Klein, 2012; 
Kania, 2016).  Due to these critical roles of ephrin signaling, aberrant ephrin signaling is 
implicated in developmental defects and diseases including neuronal defects, bone 





Figure 4:  Eph/ephrin Domain Organization and Signaling Modes.  
a) Transmembrane Eph receptor tyrosine kinases bind membrane-tethered ephrin 
ligands in trans, and therefore, ephrin signaling requires cell-cell contact.  Ephrin 
signaling affects cytoskeletal dynamics, driving changes in cell shape and cell-cell 
contacts.  Through these mechanisms, ephrin signaling contributes to cell-cell 
repulsion/adhesion, segregation, positioning, migration, proliferation, and axon 
guidance.  These cellular responses underlie the roles of ephrin signaling in 
development, such as patterning, morphogenesis, and tissue boundary formation, as 
well as the roles of ephrin signaling in tissue homeostasis, maintenance, and function in 
adult tissues.  b) Eph receptors (left) have a highly conserved domain organization, 
consisting of a globular ligand binding domain (LBD), a cysteine rich region that 
includes a Sushi and an epidermal growth factor (EGF)-like domain, two fibronectin type 
III domains (FN1 and FN2), a transmembrane (TM) helix, an intracellular 
juxtamembrane (JM) region that features several conserved tyrosine (Y) residues, a 
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tyrosine kinase domain (TK), a sterile-α motif (SAM) protein-protein interaction domain, 
and a C-terminal Psd-95, Dlg, and Z01 domain (PDZ)-binding motif.  Ephrin-A and 
ephrin-B ligands possess an extracellular receptor-binding domain (RBD). Ephrins 
(right) are divided into A and B classes based on their affinity for EphA or EphB 
receptors and whether they are tethered to the membrane via a 
glycosylphosphatidylinositol GPI linkage (class A), or as type-I transmembrane proteins 
(class B).  Unlike the GPI-anchored ephrin-A ligands, ephrin-B ligands have a TM helix, 
an intracellular region with several conserved tyrosine residues and a C-terminal PDZ-
binding motif.  The JM region of Eph receptors suppresses the intrinsic Eph kinase 
activity through auto-inhibition due to its inactive conformation.  Activation of Eph 
receptors results in phosphorylation of tyrosine residues (P) of the JM domain, which 
relieves the auto-inhibition.  The kinase domain adopts an active conformation, resulting 
in phosphorylation of the TK and SAM domains and initiation of downstream signaling 
events through phosphorylation of intracellular effectors.  Phosphorylation of the 
tyrosine residues of the intracellular domains of ephrin-B ligands also occurs in 
response to Eph-ephrin interaction, and is involved in reverse signaling.  In addition, the 
tyrosine residues of the intracellular region of ephrin-Bs are phosphorylated in response 
to binding with Eph receptors.  c) Ephrin signaling can be unidirectional (forward or 
reverse) or bidirectional (forward and reverse simultaneously), depending on the 
direction(s) of signal flow.  Arrows indicate signaling events, and X’s indicate the 
absence of signaling.  Forward signaling occurs when the signal is transduced from the 
ephrin ligand-expressing cell into the Eph receptor-expressing cell, while reverse 
signaling occurs in the opposite direction.  Bidirectional signaling occurs when both 
forward and reverse signaling occur simultaneously via the same Eph/ephrin interaction, 
simultaneously activating molecular pathways downstream of ephrins and Ephs.  
Because there may be multiple Eph/ephrin (A and/or B) and/or ephrin/Eph (A and/or B) 
interactions occurring simultaneously at the junctions between two cells, the 
phenomena of parallel and anti-parallel signaling emerge.  Parallel signaling occurs 
when two or more Eph/ephrins signal simultaneously in the same direction (forward or 
reverse), propagating forward or reverse signals in the same direction.  Anti-parallel 
signaling occurs when two or more Eph/ephrins signal simultaneously in opposite 
directions, simultaneously propagating forward signals in one direction and reverse 
signals in the opposite direction (Image reprinted with permission from Macmillan 





Figure 5:  Eph/ephrin Complexes and Receptor Clustering, and Downstream 
Molecular Pathways and Cellular Responses.  a) Ephrin ligands and Eph receptors 
interact in trans, inducing the formation of Eph/ephrin heterodimers.  These 
heterodimers bind to other Eph/ephrin heterodimers, forming heterotetramers, which 
assemble into higher-order clusters through the recruitment of other ligand-bound Eph 
receptors.  These higher-order clusters are required for forward and reverse ephrin 
signaling, and the strength of the forward and reverse signals increases with the 
recruitment of additional ligand-bound receptors.  Interestingly, Eph receptor clusters 
can laterally recruit additional Eph receptors independent of ephrins.  The tyrosine 
phosphorylation events (P), as described in Figure 4, are also shown. b) Crystal 
structure of a higher-order cluster of an ephrin-A5-EphA2 complex.  c) Schematic 
representations of downstream molecular pathways activated downstream of forward 
ephrin signaling that affect cytoskeletal changes underlying various cellular responses.  
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Forward ephrin signaling activates intrinsic tyrosine kinase activity of the Eph receptors, 
regulating the recruitment and activity of intracellular effector proteins such as non-
catalytic region of tyrosine kinase adaptor protein 1 (Nck1) and Nck2 (also known as 
Grb4), phosphoinositide 3-kinase (PI3K), Vav2 and Vav3, Src, α2-chimerin, and 
ephexins.  These effectors are coupled to Ras homology (Rho) subfamily of Ras-like 
small GTP-ases, including Ras-related C3 botulinum toxin substrate 1 (Rac1), cell 
division control protein 42 homolog (Cdc42), and RhoA.  By regulating the activity of Src 
family kinases and Ras/Rho family GTP-ases, ephrin signaling affects cytoskeletal 
dynamics.  d) The mechanism of reverse ephrin-B signaling is not well understood, but 
one mechanism involves recruitment of Src family kinases and tyrosine phosphorylation 
of its intracellular domain.  These events lead to the recruitment of PDZ domain-
containing proteins, and possibly other effectors, such as the SH2/SH3 adaptor Grb4, 
p21 protein (Cdc42/Rac)-activated kinase 1 (Pak1), and dedicator of cytokinesis 1 
(Dock180), which then elicit cellular responses.  Reelin can also bind to ephrin-B1 and 
ephrin-B3, leading to the activation of disabled 1 (Dab1), which elicits cellular 
responses.  Although ephrin-A ligands lack an intracellular region, and therefore are not 
phosphorylated intracellularly, they also participate in reverse signaling by coupling to 
co-receptors, such as the Src family tyrosine kinase, Fyn, and the receptor tyrosine 
kinase, Ret, which elicit cellular responses (Image reprinted with permission from 
Macmillan Publishers Ltd: Nature Reviews Molecular Cell Biology [Kania, 2016], 
Copyright © 2016).  
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1.3: Canonical Wnt – ephrin-B Crosstalk 
1.3.1: Evidence of Canonical Wnt – ephrin-B Crosstalk 
Wnt signaling and ephrin-B signaling are both involved in regulation of the 
intestinal stem cell niche, and the normal tissue homeostasis of the intestine (Clevers, 
2006b).  The small intestine contains protrusion known as villi, and the basal areas 
between these villi are known as crypts.  The cells in the intestinal crypts are stem cells 
and Paneth cells, which express EphB receptors (EphB2, EphB3, and EphB4) (Clevers, 
2006b; Kania, 2016).  As these cells differentiate, they proliferate and migrate up the villi from 
the intestinal crypt and come into contact with the differentiated cells at the apical 
portion of the villi, which express ephrin-B1 and ephrin-B2 (Clevers, 2006b; Kania, 2016).  Cell-
cell contact and the initiation of EphB/ephrin-B signaling between the ephrin-B1/B2 
expressing cells and the migrating EphB cells from the crypt leads to the loss of EphB 
expression in these cells, allowing for their differentiation and normal tissue 
homeostasis (Clevers, 2006b; Kania, 2016).  These events result in the formation of a gradient of 
EphB expression that is strongest at the base of the crypts and weakest at the apical 
portion of the villi, and an opposing ephrin-B gradient that is strongest at the apical 
portion of the villi and weakest at the base of the crypts (Clevers, 2006b; Kania, 2016).  Loss of 
ephrin-B signaling disrupts cell proliferation and positioning along the villus – crypt axis 
(Kania, 2016).  Mutations in the tumor suppressor gene APC (APCmut) leads to the 
constitutive activation of canonical Wnt signaling, and the transformation of these cells 
into tumor-initiating cells (cells inside the box labeled APCmut) (Clevers, 2006b).  These 
proliferate and migrate up the crypt, accumulating at the villi and forming benign poly-
like outgrowths, or adenomas (Clevers, 2006b).  These tumor-initiating cells express high 
levels of EphB receptors, and contact of these cells with normal differentiated cells 
expressing high levels of ephrin-B ligands at the apical portion of the villi results in 
activation of ephrin-B signaling (Clevers, 2006b).  EphB repulsive signals limit the spread of 
the tumor.  These findings illustrate how the orchestration of canonical Wnt and ephrin 
signaling programs can contribute to normal development and tissue homeostasis, and 
disruption of these signaling gradients can result in colorectal cancer. 
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Direct inhibition of Wnt signaling by ephrin-B signaling was suggested by the 
finding that the metalloprotease ADAM13 cleaves ephrin-B1, permitting canonical Wnt 
signaling during cranial neural crest (CNC) induction in Xenopus tropicalis embryos (Wei, 
2010).  Furthermore, wild-type Xenopus ephrin-B1 (ephrin-B1WT) and ephrin-B1ΔC (a 
mutant ligand that lacks the cytoplasmic tail and hence only promotes forward, but not 
reverse, ephrin signaling) inhibit Wnt reporter (TOP/FOP FLASH) expression when Wnt 
signaling is activated by Wnt8 in Xenopus tropicalis embryos and by Wnt3a in human 
embryonic kidney (HEK293T) cells (Wei, 2010). 
It has been shown previously that decreased nuclear β-catenin is a consequence 
of increased ephrin signaling through Eph receptors during carcinogenesis (Chiu, 2009).  
Taken together, these data indicate a novel crosstalk between Wnt and ephrin signaling 
axes in which ephrin-B signaling antagonizes canonical Wnt signaling.  The molecular 
mechanism that mediates this antagonistic interaction is unknown.  Furthermore, this 
antagonistic interaction provides a unique system in which to investigate the 
mechanisms of inhibition of canonical Wnt signaling.  Canonical Wnt signaling can be 
modulated through interactions at various levels of the canonical Wnt signaling axis 
including 1) ligand – receptor and receptor – receptor interactions, 2) β-catenin stability, 
3) β-catenin localization, and 4) β-catenin/TCF/LEF/DNA interactions (Figure 8).  
Therefore, we aimed to gain insight into the mechanisms of ephrin-B antagonism of 





Figure 6: Canonical Wnt and Eph/ephrin Interactions in the Intestinal Stem Cell 
Niche and Colorectal Cancer Progression.  The small intestine contains protrusion 
known villi, and the basal areas between these villi are known as crypts.  1) The cells in 
the intestinal crypts are stem cells and Paneth cells, which express EphB receptors 
(EphB2, EphB3, and EphB4).  As these cells differentiate, they proliferate and migrate 
up the villi from the intestinal crypt and come into contact with the differentiated cells at 
the apical portion of the villi, which express ephrin-B1 and ephrin-B2.  Cell-cell contact 
and the initiation of EphB/ephrin-B signaling between the ephrin-B1/B2 expressing cells 
and the migrating EphB cells from the crypt leads to the loss of EphB expression in 
these cells, allowing for their differentiation and normal tissue homeostasis.  These 
events result in the formation of a gradient of EphB expression that is strongest at the 
base of the crypts and weakest at the apical portion of the villi, and an opposing ephrin-
B gradient that is strongest at the apical portion of the villi and weakest at the base of 
the crypts.  Loss of ephrin-B signaling disrupts cell proliferation and positioning along 
the villus – crypt axis.  2) Mutations in the tumor suppressor gene APC (APCmut) leads 
to the constitutive activation of canonical Wnt signaling, and the transformation of these 
cells into tumor-initiating cells (cells inside the box labeled APCmut).  These proliferate 
and migrate up the crypt, accumulating at the villi and forming benign poly-like 
outgrowths, or adenomas.  3) These tumor-initiating cells express high levels of EphB 
receptors, and contact of these cells with normal differentiated cells expressing high 
levels of ephrin-B ligands at the apical portion of the villi results in activation of ephrin-B 
signaling.  4) EphB repulsive signals limit the spread of the tumor (Image reprinted with 





Figure 7: Wild-type ephrin-B and ephrin-B1ΔC Inhibit Wnt3a – Induced Reporter 
Activity.  HEK293T cells were transfected with pTOP FLASH (TOP) and pFOP FLASH 
(FOP) and the indicated constructs and cultured for ~40 hours.  Cell lysates were 
processed for luciferase assays.  A representative experiment performed in triplicate is 
shown here.  Results are presented as average ratios of TOP vs. FOP luciferase 
activity, and the error bars represent standard deviations. *: P < 0.05, **: P < 0.01, *** P 
< 0.001 (Image reprinted with permission from Elsevier Inc: Developmental Cell [Wei, 
2010; supplement] Copyright © 2010 Elsevier Inc).  
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Figure 8: Regulation of the Wnt Signaling Axis.  Canonical Wnt signaling can be 
modulated through interactions at various levels of the canonical Wnt signaling axis 
including 1) ligand – receptor and receptor – receptor interactions, 2) β-catenin stability, 
3) β-catenin localization, and 4) β-catenin/TCF/LEF/DNA interactions (Image adapted 
with permission from InTechOpen: Image Copyright © 2013 Inestrosa, N.C., Varela-
Nallar, L. Published in [Wislet, 2013] under CC BY 3.0 license).  
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1.3.2: Regulators of β-catenin Stability and Localization 
β-catenin levels and β-catenin subcellular localization are affected by interactions 
with protein modifiers within the cell, and other cellular signaling pathways.  β-catenin is 
modified by GSK3β and c-Jun N-terminal kinase 1 and 2 (JNK1, JNK2), and 
adenomatous polyposis coli (APC) and Ras-related C3 botulinum toxin substrate 1 
(Rac1) affect β-catenin subcellular localization (Liu, 2002; Zeng, 2005; Hu, 2008; Hu, 2009; Henderson, 
2000; Wang, 2014; Wu, 2008).  In addition, classical cadherins, such as E-cadherin, sequester β-
catenin to the cell membrane through the binding of β-catenin to the cytoplasmic tail of 
E-cadherin, resulting in a decrease in nuclear β-catenin and Wnt signaling activation 
(Conacci-Sorrell, 2003).  Therefore, dense cell cultures have lower nuclear β-catenin and Wnt 
signaling activation than sparse cell cultures (Conacci-Sorrell, 2003).  These effectors of β-
catenin stability and β-catenin subcellular localization represent potential nexuses 
through which ephrin-B signaling may interact with Wnt signaling. 
1.3.3: c-Jun N-terminal kinase 1 and 2 (JNK1, JNK2) 
One intriguing possible mediator of the ephrin-B induced antagonism of 
canonical Wnt signaling is JNK.  JNK is a downstream target of forward ephrin signaling 
and can prevent nuclear β-catenin accumulation (Stein, 1998; Liao, 2006).  In addition, it has 
previously been demonstrated that JNK1 and JNK2 can affect the stability, amount and 
subcellular localization of β-catenin (Hu, 2008; Hu, 2009; Wu, 2008).  JNK1 and JNK2 cause a 
reduction in β-catenin in HEK293T cells, with JNK2 causing a greater reduction in β-
catenin than JNK1, and this reduction in β-catenin occurs through the ubiquitin-
proteasome system (UPS) and is mediated by GSKβ (Hu, 2008; Hu, 2009).  Furthermore, 
preliminary data from Laura Christian, a former post-doc in the Wei lab, indicates that 
co-transfection of ephrin-B1ΔC and EphB2 in HeLa cells results in an increase in JNK 
activity (Figure 9) (Christian et al., unpublished).  Therefore, we propose that ephrin-B signaling 
antagonizes canonical Wnt signaling by activating JNK, preventing nuclear 






Figure 9: Ephrin-B Signaling Activates c-Jun N-terminal kinase (JNK).  HeLa cells 
were transfected to express the indicated proteins, and in vitro JNK activity assays were 
carried out using a JNK Kinase Assay Kit (Cell Signaling Technology; 8794). JNK was 
pulled down from cell lysates by using an α JNK antibody, and incubated with 
recombinant c-Jun protein. Western blot was performed by using an α phospho-c-Jun 





Figure 10: Proposed Models for JNK-mediated ephrin-B Antagonism of Canonical 
Wnt Signaling.  (Model A) Forward ephrin-B signaling results in intracellular activation 
of Dvl.  Dvl activates downstream signaling events and initiates PCP signaling, which 
inhibits canonical Wnt signaling. (Model B) Forward ephrin-B signaling results in 
downstream activation of JNK.  JNK interacts with and modifies β-catenin, triggering 




Chapter 2: Specific Aims 
2.1: Specific Aims 
1) To test if the ephrin-B antagonism of canonical Wnt signaling first described in 
Xenopus laevis is conserved in mammals. 
2) To determine the cellular processes that mediate this crosstalk by investigating 
the effects of ephrin-B signaling on the 2a) stabilization and 2b) subcellular 
localization of β-catenin. 
3) To determine how downstream effectors of ephrin-B signaling may interact with 




2.2: Specific Aims Approaches 
Aims 1 and 2a were addressed using the TOP/FOP FLASH luciferase reporter 
assay as a read-out of activation of canonical Wnt signaling.  Overexpression of 
canonical Wnt ligands (Wnt3a or Wnt8), wild-type β-catenin (β-catenin WT), or a β-
catenin mutant (β-catenin*), or lithium chloride (LiCl) treatment were used to activate 
TOP/FOP FLASH reporter activity in human embryonic kidney (HEK293T) cells.  LiCl 
inhibits GSK3β, blocking phosphorylation of β-catenin and preventing its degradation by 
the UPS (Zhang, 2003).  Similarly, β-catenin* has serine (S)/threoinine (T) to aspartic acid 
(D) point mutations at Ser33, Ser37, Thr41, and Ser45, and cannot be modified by the 
destruction complex.  Expression of a mouse ephrin-B1 ligand lacking the cytoplasmic 
domain, ephrin-B1ΔC, in the presence of an activator of canonical Wnt (overexpression 
of Wnt ligands, β-catenin, or β-catenin*, or LiCl treatment) was tested to determine if 
ephrin-B antagonism of canonical Wnt signaling reported in Xenopus is conserved in 
mammals, and whether or not this effect depends on the normal function of the 
endogenous regulation of β-catenin stability via GSK3β. 
Aim 2a was addressed by measuring changes in total cellular β-catenin in 
HEK293T cell lysates in response to canonical Wnt and ephrin-B signaling.  The 
relevant Western blots were quantified using Image J (Schindelin, 2012; Walter, 2010; Eliceiri, 2012).  
In accordance with Aim 2b, the subcellular localization of β-catenin was observed using 
confocal immunofluorescence microscopy.  These images were prepared and analyzed 
using the image analysis software Adobe Illustrator, Fiji (Image J), and Vaa3d (Schindelin, 
2012; Walter, 2010; Eliceiri, 2012; Peng, 2010; Peng, 2014).  This analysis allowed visualization of the 
subcellular localization of β-catenin (in 3-D) in response to canonical Wnt and ephrin-B 
signaling. 
 Aim 3 was addressed by investigating the role of JNK in mediating the ephrin-B 
antagonism of canonical Wnt signaling.  The activation of JNK by ephrin-B signaling 
was reaffirmed using an in vitro JNK assay (Christian et al., unpublished data).  Inhibition of JNK 
using the JNK inhibitor, SP600125, and analysis of the corresponding effects on LiCl - 
induced activation of canonical Wnt signaling (TOP/FOP FLASH) was used to indicate 
30 
 
whether or not inhibition of JNK activity is sufficient to reverse the antagonistic effect of 




Chapter 3: Methods 
A combination of cell-based assays, biochemical techniques, and confocal 
immunofluorescence microscopy in HEK293T cells were used to investigate the 
molecular mechanisms of ephrin-B antagonism of canonical Wnt signaling.   
pCS2 vector-based plasmids were constructed previously including Mus 
musculus HA-ephrin-B1ΔC (ephrin-B1ΔC), wild-type Xenopus laevis β-catenin (β-
cateninWT), a mutant Xenopus laevis β-catenin that is constitutively active, β-catenin* 
(S33/37/41/T45D), Wnt3a, and Wnt8.  In addition, pTOP FLASH (TOP) and pFOP 
FLASH (FOP) luciferase reporter plasmids were obtained commercially (EMD Millipore; 
21-170).   
HEK293T cells were seeded and grown in Dulbecco’s Modified Eagle Medium 
(DMEM) high glucose (Gibco; 11965-092) supplemented with 5% fetal bovine serum 
(FBS) and 1:100 penn/strep at a controlled density for ~24 hours.  When the pan-JNK 
inhibitor, SP600125 (abcam; ab120065), was used, it was mixed with fresh DMEM 
media, and added to the appropriate wells, replacing the existing media after ~24 hours 
of growth post-seeding.  Auto H20 (vehicle control for LiCl) and DMSO vehicle controls 
were added in the same fashion as SP60125, as necessary, to evaluate any potential 
effects of these vehicles on the results.  Lipofectamine-based transfections (Invitrogen; 
L3000015) of these plasmids were performed after ~24 hours of growth post-seeding.  
For immunofluorescence experiments, the cells were grown on poly-D-lysine (molecular 
weight 70,000-150,000) coated coverslips (Sigma; P6407).  Following transfection, the 
cells were incubated at 37°C for ~24 hours.  The cells were then harvested and lysed in 
preparation for TOP/FOP FLASH luciferase reporter assay, Western blot, or other 
biochemical analysis, or fixed in preparation for immunofluorescence treatment and 
confocal microscopy.   
The TOP/FOP FLASH luciferase reporter assay was performed according to the 
manufacturer’s protocol and recommendation (Promega; E1500).  The Spectra max 
GeminiXPS plate reader and the SoftMax Pro 6 software from Molecular Devices were 
used in luminescence mode to measure the luminescence in relative luminescence 
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units (RLU) of the assayed cell lysate samples.  The average and standard deviation of 
the RLU measurements of three replicates of each treatment performed in parallel were 
calculated using Microsoft Excel. 
The Western blots were blocked with 5% bovine serum albumin (BSA) for one 
hour at room temperature with shaking.  Polyclonal rabbit α β-catenin (Sigma; C2206) 
was applied at a dilution of 1:4,000 and incubated overnight at 4°C with shaking.  
Polyclonal goat α rabbit horseradish peroxidase (HRP) secondary antibody (Sigma; 
A0545) was applied to each Western blot at a dilution of 1:25,000, and incubated for 30 
minutes at room temperature with shaking.  The HRP substrate was applied, and the 
Western blots were imaged using the ProteinSimple FluorChem Q system and the 
AlphaView 3.4.0 software.  The Western blots were stripped and blotted for β-actin by 
applying monoclonal mouse α β-actin HRP clone AC-15 (Sigma; A3854) at a dilution of 
1:25,000, and incubated for 30 min at room temperature with shaking.  The HRP 
substrate was applied and the Western blots were imaged as described above.  Two of 
the three Western blots were re-stripped and blotted for E-cadherin by applying 
monoclonal rabbit α E-cadherin clone 24E10 (Cell Signaling Technology; 3195) at a 
dilution of 1:1,000, and incubating overnight at 4°C with shaking.  The HRP substrate 
was applied to the Western blots and they were imaged as described above.  The 
Western blot images were quantified by calculating the integrated density of each band 
using the Image analysis software Image J (Schindelin, 2012; Walter, 2010; Eliceiri, 2012). The 
normalized values (adjusted relative density) of the signals were obtained by dividing 
the integrated density of the protein of interest band by the integrated density of the β-
actin band of that same sample.  The average and standard deviation of the adjusted 
relative density values of β-catenin under each treatment from three replicate Western 
blots were calculated. 
For immunofluorescence, the cells were fixed with 1:1 methanol:acetone.  The 
cells were blocked with blocking buffer (5% lamb serum, 0.3% Triton X-100 in 1x 
phosphate buffered saline (PBS)) for one hour at room temperature in a humid, light-
tight box.  Polyclonal rabbit α β-catenin (Sigma; C2206) and monoclonal mouse α HA 
clone HA-7 (Sigma; H9658) primary antibodies were applied at dilutions of 1:1000 as 
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necessary, and incubated overnight at 4°C in a humid, light-tight box.  Donkey α rabbit 
CF633 (Biotium; 20125) and polyclonal donkey α mouse Alexa 488 (Jackson 
ImmunoResearch Laboratories; 715-545-150) fluorescently conjugated secondary 
antibodies were each applied at the concentration 10 µg/mL, as necessary, to label β-
catenin and ephrin-B1ΔC (HA), respectively, and incubated for one hour at room 
temperature in a humid, light-tight box.  The coverslips on which the cells were grown 
and fixed were mounted onto a microscope slide using Vectashield (Vector 
Laboratories; H-1000).  The slides were imaged via Z-scan at 600x magnification using 
an Olympus Fluoview FV1000 confocal microscope and the Olympus Fluoview 4.1 
software.  Following fluorescent microscopy, the images obtained were prepared and 
analyzed using the imaging software Adobe Illustrator, Fiji (Image J), and Vaa3d 
(Schindelin, 2012; Walter, 2010; Eliceiri, 2012; Peng, 2010; Peng, 2014).  
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Chapter 4: Results 
Overexpression of the canonical Wnt ligands Wnt3a and Wnt8 was not sufficient 
to induce TOP/FOP FLASH reporter activity (Figures 11 and 12).  Overexpression of 
wild-type β-catenin (β-cateninWT), however, was sufficient to induce TOP/FOP FLASH 
reporter activity (Figure 13).  Co-expression of mouse ephrin-B1ΔC inhibited β-
cateninWT – induced TOP/FOP FLASH reporter activity (Figure 14).  Similarly, 24 hour 
LiCl treatment induced TOP/FOP FLASH reporter activity (Figure 15), and 
overexpression of mouse ephrin-B1ΔC abrogated the LiCl – induced TOP/FOP FLASH 
reporter activity (Figure 16).  β-catenin* overexpression also induced TOP/FOP FLASH 
reporter activity (Figure 17).  Co-expression with ephrin-B1ΔC abrogated the β-catenin* 
– induced TOP/FOP FLASH reporter activity (Figure 18). 
Levels of total cellular β-catenin were deduced by calculating the adjusted 
relative density and the average and standard deviation of the adjusted relative density 
values of β-catenin under each treatment from three replicate Western blots.  LiCl 
treatment results in an increase in total cellular β-catenin (Figures 19 and 20).  
Furthermore, overexpression of ephrinB1ΔC in the presence of LiCl treatment reduced 
the increase in total cellular β-catenin observed with LiCl alone (Figures 19 and 20).  
However, the increase in total cellular β-catenin upon LiCl treatment and the reduction 
of this effect with the addition of overexpression of ephrin-B1ΔC, as measured by the 
adjusted relative density of α β-catenin in Western blots, varied greatly among 
replicates (only one replicate is shown; Figure 19).  Indeed, these results were not 
statistically significant, as revealed by t-test’s. 
Levels of total cellular E-cadherin were deduced by calculating the adjusted 
relative density values of E-cadherin under each treatment from two replicate Western 
blots (one replicate is shown; Figure 21).  Total cellular E-cadherin increased in 
response to LiCl treatment Figure 21).  Total cellular E-cadherin also increased in 
response to ephrin-B1ΔC overexpression (Figure 21).  In one replicate Western blot for 
E-cadherin, overexpression of ephrin-B1ΔC together with LiCl treatment did not affect 
the increase in total cellular E-cadherin observed in response to LiCl treatment alone 
(Figure 21) However, in another replicate Western blot for total cellular E-cadherin, 
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overexpression of ephrin-B1ΔC together with 50 mM LiCl enhanced the observed 
increase in total cellular E-cadherin (data not shown).  However, more experiments 
need to be performed to verify these effects. 
Analysis of β-catenin subcellular localization using confocal immunofluorescence 
microscopy revealed that β-catenin subcellular localization varies in apical, middle, and 
basal Z-sections of HEK293T cells cultured to confluency (Figure 22).  Membrane-
localized β-catenin is very prominent at apical Z-sections, and is also apparent at basal 
Z-sections (Figure 22-25).  Cytoplasmic β-catenin is observed in all Z-positions, 
however, cytoplasmic space is lacking in HEK293T cells, especially once they form cell-
cell interactions and become more tightly organized (Figure 22-25).  Nuclear β-catenin 
is observed in some cells in the middle and apical Z-sections, and nuclear β-catenin 
punctae are observed in some cells in the apical Z-sections, particularly (Figure 22-25).  
LiCl treatment may enhance membrane localization of β-catenin at basal and, more 
prominently, apical Z-sections, and may enhance nuclear β-catenin punctae at apical Z-
sections (Figure 22-25).  Overexpression of ephrinB1ΔC also enhances membrane 
localization of β-catenin at basal and apical Z-sections, and the effect is even more 
prominent when LiCl treatment is applied in addition to overexpression of ephrin-B1ΔC 
(Figure 22-25). 
SP600125 does not prevent inhibition of LiCl – induced TOP/FOP FLASH 
reporter expression by ephrin-B1ΔC (Figure 26).  Rather, SP600125 seems to enhance 





Figure 11: Wnt3a Overexpression is Not Sufficient to Induce Reporter Activity.  
HEK293T cells were grown at a controlled density for ~24 hours.  The cells were 
transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated 
constructs and cultured for ~24 hours.  Cell lysates were processed for luciferase 
assays.  A representative experiment performed in triplicate is shown here.  Results are 
presented as average ratios of TOP vs. FOP luciferase activity measured as relative 
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05, 




Figure 12: Wnt8 Overexpression is Not Sufficient to Induce Reporter Activity.  
HEK293T cells were grown at a controlled density for ~24 hours.  The cells were 
transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated 
constructs and cultured for ~24 hours.  Cell lysates were processed for luciferase 
assays.  A representative experiment performed in triplicate is shown here.  Results are 
presented as average ratios of TOP vs. FOP luciferase activity measured as relative 
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05, 




Figure 13: Wild-type β-catenin Overexpression Induces Reporter Activity.  
HEK293T cells were grown at a controlled density for ~24 hours.  The cells were 
transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated 
constructs and cultured for ~24 hours.  Cell lysates were processed for luciferase 
assays.  A representative experiment performed in triplicate is shown here.  Results are 
presented as average ratios of TOP vs. FOP luciferase activity measured as relative 
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05, 






Figure 14: ephrin-B1ΔC Inhibits Wild-type β-catenin – Induced Reporter Activity.  
HEK293T cells were grown at a controlled density for ~24 hours.  The cells were 
transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated 
constructs and cultured for ~24 hours.  Cell lysates were processed for luciferase 
assays.  A representative experiment performed in triplicate is shown here.  Results are 
presented as average ratios of TOP vs. FOP luciferase activity measured as relative 
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05, 




Figure 15: LiCl Induces Reporter Activity.  HEK293T cells were grown at a controlled 
density for ~24 hours.  The cells were treated with 50 mM LiCl, transfected with pTOP 
FLASH (TOP) and pFOP FLASH (FOP) and the indicated constructs, and cultured for 
~24 hours.  Cell lysates were processed for luciferase assays.  A representative 
experiment performed in triplicate is shown here.  Results are presented as average 
ratios of TOP vs. FOP luciferase activity measured as relative luminescence units 





Figure 16: ephrin-B1ΔC Inhibits LiCl – Induced Reporter Activity.  HEK293T cells 
were grown at a controlled density for ~24 hours.  The cells were treated with 50 mM 
LiCl, transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated 
constructs, and cultured for ~24 hours.  Cell lysates were processed for luciferase 
assays.  A representative experiment performed in triplicate is shown here.  Results are 
presented as average ratios of TOP vs. FOP luciferase activity measured as relative 
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05, 





Figure 17: β-catenin* Overexpression Induces Reporter Activity.  HEK293T cells 
were grown at a controlled density for ~24 hours.  The cells were transfected with pTOP 
FLASH (TOP) and pFOP FLASH (FOP) and the indicated constructs and cultured for 
~24 hours.  Cell lysates were processed for luciferase assays.  A representative 
experiment performed in triplicate is shown here.  Results are presented as average 
ratios of TOP vs. FOP luciferase activity measured as relative luminescence units 






Figure 18: ephrin-B1ΔC Inhibits β-catenin* – Induced Reporter Activity.  HEK293T 
cells were grown at a controlled density for ~24 hours.  The cells were transfected with 
pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated constructs and cultured 
for ~24 hours.  Cell lysates were processed for luciferase assays.  A representative 
experiment performed in triplicate is shown here.  Results are presented as average 
ratios of TOP vs. FOP luciferase activity measured as relative luminescence units 
(RLU), and the error bars represent standard deviations. *: P < 0.05, **: P < 0.01, *** P 




Figure 19: ephrin-B Signaling Affects Levels of Total Cellular β-catenin.  HEK293T 
cells were grown at a controlled density for ~24 hours.  The cells were treated with 50 
mM LiCl, transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the 
indicated constructs, and cultured for ~24 hours.  Western blots of whole cell lysates 
were carried out using α β-catenin. The Western blots were stripped and blotted for α β-
actin.  The adjusted relative density of each β-catenin band was calculated using Fiji, 
and normalized (to obtain the adjusted relative density) for the relative amount of cell 
lysate by dividing the integrated density of each β-catenin band by the respective 
integrated density of the respective β-actin band and setting the adjusted relative 




Figure 20: ephrin-B Signaling Affects Levels of Total Cellular β-catenin.  The 
averages and standard deviations of the adjusted relative densities of α β-catenin from 
three Western blots of cell lysates from three biological replicates of each treatment 




Figure 21: LiCl and ephrin-B Signaling Increase Levels of Total Cellular  
E-cadherin Independently and Co-Treatment Does Not Influence this Effect.  
HEK293T cells were grown at a controlled density for ~24 hours.  The cells were treated 
with 50 mM LiCl, transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and 
the indicated constructs, and cultured for ~24 hours.  Two of the Western blots of whole 
cell lysates blotted for  α β-catenin and α β-actin were re-stripped and blotted for α E-
cadherin (hence, α β-actin image is reproduced from Figure 19), and one of these 
Western blots is shown.  The adjusted relative density of each β-catenin band was 
calculated using Fiji, and normalized (to obtain the adjusted relative density) for the 
relative amount of cell lysate by dividing the integrated density of each β-catenin band 
by the respective integrated density of the respective β-actin band and setting the 
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Figure 26: Inhibition of c-Jun N-terminal kinase (JNK) Inhibits LiCl – Induced 
Reporter Activity and Enhances the ephrin-B1ΔC Inhibition of LiCl – Induced 
Reporter Activity.  HEK293T cells were grown at a controlled density for ~24 hours.  
50 µM SP600125 (pan-JNK inhibitor), 0.1% DMSO (vehicle control for SP600125), or 
0.01% auto H20 (vehicle control for LiCl) were added to fresh DMEM, and the media of 
the cells was replaced as necessary. The cells were treated with 50 mM LiCl, 
transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated 
constructs, and cultured for ~24 hours.  Cell lysates were processed for luciferase 
assays.  A representative experiment performed in triplicate is shown here.  Results are 
presented as average ratios of TOP vs. FOP luciferase activity measured as relative 
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05, 




Chapter 5: Discussion 
As described earlier, the ephrin-B antagonism of canonical Wnt signaling was 
initially suggested in a TOP/FOP FLASH assay in HEK293T cells using Xenopus 
ephrin-B1 and ephrin-B1ΔC.  Therefore, we aimed to validate this novel interaction 
using a TOP/FOP FLASH assay in HEK293T cells using Mus musculus constructs in 
order to determine if this interaction is evolutionarily conserved in mammals.  
Overexpression of mammalian ephrin-B1ΔC in HEK293T cells inhibits TOP/FOP 
FLASH reporter activity induced by the application of LiCl, and overexpression of 
mammalian WT β-catenin and β-catenin* (Figures 16,14, and 18).  These results 
suggest that the ephrin-B antagonism of canonical Wnt signaling is evolutionarily 
conserved between amphibians and mammals. 
Because ephrin-Bs can mediate both forward and reverse signaling, we 
employed two ephrin-B constructs to determine whether forward or reverse ephrin-B 
signaling is responsible for the ephrin-B mediated antagonism of canonical Wnt 
signaling.  Ephrin-B1 mediates both forward and reverse signaling, while ephrin-B1ΔC 
mediates forward signaling, and when overexpressed, can dominant-negatively inhibit 
reverse signaling.  Because ephrin-B1 and ephrin-B1ΔC had similar effects on LiCl, β-
cateninWT, and β-catenin* - induced TOP/FOP FLASH reporter activity, we propose 
that the ephrin-B antagonism of canonical Wnt signaling in HEK293T cells is likely relies 
on forward, rather than reverse, ephrin-B signaling (Figures 16, 14, and 18; ephrin-B1 
data: Perfetto et al. unpublished data). 
Due to the central role of β-catenin in canonical Wnt signaling, we hypothesized 
that the ephrin-B antagonism of canonical Wnt signaling likely involves an alteration of 
the stability and/or subcellular localization of β-catenin.  To determine whether the 
ephrin-B antagonism of canonical Wnt signaling is dependent on the destruction 
complex-mediated degradation of β-catenin, we employed LiCl, which activates 
canonical Wnt signaling by inhibiting GSK3β, thereby preventing the degradation of β-
catenin whether it is newly synthesized β-catenin or β-catenin released from other 
interactors.  We also employed a β-catenin mutant described previously, β-catenin* that 
has mutations in the GSK3β-targeted sites and hence cannot be modified by the 
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destruction complex.  Overexpression of ephrin-B1ΔC inhibits LiCl-induced TOP/FOP 
FLASH activity in HEK293T cells (Figure 16).  Similarly, overexpression of ephrin-B1ΔC 
inhibits β-catenin* - induced TOP/FOP FLASH activity in HEK293T cells (Figure 18).  
Taken together, these results suggest that the ephrin-B can antagonize canonical Wnt 
signaling independently of the β-catenin destruction complex, and likely inhibits 
canonical Wnt signaling downstream of the destruction complex.  However, we cannot 
rule out additional effects upstream or at the level of regulation of β-catenin stability via 
GSK3β and the β-catenin destruction complex.  In line with this latter hypothesis, 
Western blots for β-catenin indicate that the ephrin-B antagonism of canonical Wnt 
signaling may involve a reduction in total cellular β-catenin levels (Figures 19 and 20). 
We employed immunofluorescence microscopy to investigate the effects of 
ephrin-B signaling on the subcellular localization of β-catenin.  As shown in 22-25, 
ephrin-B signaling may affect β-catenin subcellular localization, increasing the relative 
amount of β-catenin at the cell membrane.  Because total cellular β-catenin is 
distributed among membrane-bound, cytosolic and nuclear pools, an increase in the 
membrane-bound pool may result in reduction of the nuclear pool of β-catenin, which is 
the only fraction that is functional in mediating canonical Wnt signaling. To further test 
this hypothesis, we are in the process of quantifying functional β-catenin in HEK293T 
cells with and without ectopic ephrin-B1ΔC by purifying nuclear proteins from the cell 
lysates. 
JNK is activated downstream of ephrin-B signaling and JNK 1 and 2 directly 
interact with and phosphorylate β-catenin.  However, there are conflicting reports 
regarding the result of the JNK-phosphorylation of β-catenin (Hu, 2008; Hu, 2009; Liao, 2006; Wu, 
2008).  In addition, JNK 1 and 2- phosphorylation of β-catenin may have opposite effects.  
We confirmed that JNK is activated in response to ephrin-B signaling in HEK293T cells 
using a JNK Assay Kit (Figure 9).  Furthermore, we employed the pan-JNK inhibitor, 
SP600125, to determine if JNK activity is required for the ephrin-B antagonism of 
canonical Wnt signaling.  As shown in Figure 26, inhibition of JNK using SP600125 
does not prevent the ephrin-B – mediated inhibition of LiCl or β-catenin* – induced 
TOP/FOP FLASH activity, but rather seems to enhance the effect (Figure 26).  In 
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addition, inhibition of JNK alone inhibits LiCl – induced TOP/FOP FLASH activity (Figure 
26).  This result is consistent with reports that JNK-phosphorylation of β-catenin results 
in nuclear accumulation of β-catenin, and activates canonical Wnt signaling in HEK293T 
cells (Wu, 2008).  Future efforts will be focused on testing if other effectors of forward 
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